###begin article-title 0
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 38 43 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Nuclear Retention of Multiply Spliced HIV-1 RNA in Resting CD4+ T Cells
###end article-title 0
###begin p 1
###xml 28 29 28 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 238 239 238 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 540 541 540 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 840 841 840 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1113 1114 1113 1114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1160 1161 1160 1161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1304 1305 1304 1305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1389 1390 1389 1390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
###xml 202 207 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 253 261 <span type="species:ncbi:9606">patients</span>
###xml 343 348 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 555 563 <span type="species:ncbi:9606">patients</span>
###xml 635 638 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 722 727 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 959 964 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1034 1039 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1175 1183 <span type="species:ncbi:9606">patients</span>
###xml 1229 1234 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1404 1412 <span type="species:ncbi:9606">patients</span>
HIV-1 latency in resting CD4+ T cells represents a major barrier to virus eradication in patients on highly active antiretroviral therapy (HAART). We describe here a novel post-transcriptional block in HIV-1 gene expression in resting CD4+ T cells from patients on HAART. This block involves the aberrant localization of multiply spliced (MS) HIV-1 RNAs encoding the critical positive regulators Tat and Rev. Although these RNAs had no previously described export defect, we show that they exhibit strict nuclear localization in resting CD4+ T cells from patients on HAART. Overexpression of the transcriptional activator Tat from non-HIV vectors allowed virus production in these cells. Thus, the nuclear retention of MS HIV-1 RNA interrupts a positive feedback loop and contributes to the non-productive nature of infection of resting CD4+ T cells. To define the mechanism of nuclear retention, proteomic analysis was used to identify proteins that bind MS HIV-1 RNA. Polypyrimidine tract binding protein (PTB) was identified as an HIV-1 RNA-binding protein differentially expressed in resting and activated CD4+ T cells. Overexpression of PTB in resting CD4+ T cells from patients on HAART allowed cytoplasmic accumulation of HIV-1 RNAs. PTB overexpression also induced virus production by resting CD4+ T cells. Virus culture experiments showed that overexpression of PTB in resting CD4+ T cells from patients on HAART allowed release of replication-competent virus, while preserving a resting cellular phenotype. Whether through effects on RNA export or another mechanism, the ability of PTB to reverse latency without inducing cellular activation is a result with therapeutic implications.
###end p 1
###begin title 2
Synopsis
###end title 2
###begin p 3
###xml 84 85 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 742 743 742 743 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 896 897 896 897 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 403 408 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 457 462 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 492 497 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 764 769 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1024 1029 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1179 1184 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 has the ability to establish a state of latent infection in resting memory CD4+ T cells. These latently infected cells represent a stable reservoir for the virus that is a major barrier to viral eradication. Understanding how this reservoir is established, maintained, and reactivated is essential for developing methods to target and eliminate these cells. Currently, many proposed mechanisms of HIV-1 latency involve a dramatic reduction in ongoing HIV-1 transcription. However, some HIV-1 mRNAs are made, and it has been unclear why the cells are unable to produce virus. This study describes the surprising observation that mRNAs encoding the viral regulatory proteins Tat and Rev are retained in the nucleus of infected resting CD4+ T cells. A cellular HIV-1 RNA-binding protein called polypyrimidine tract binding protein was shown to reverse latency when overexpressed in resting CD4+ T cells. This overexpression of polypyrimidine tract binding protein was sufficient to allow release of replication-competent HIV-1 from latently infected cells without inducing cellular stimulation. These experiments suggest that multiple factors contribute to the maintenance of HIV-1 latency in vivo; however, perturbation of the level of a specific cellular protein is sufficient to overcome these blocks and allow for virus production.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 189 190 189 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b001">1</xref>
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b003">3</xref>
###xml 297 298 297 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b004">4</xref>
###xml 310 311 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b008">8</xref>
###xml 366 367 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b009">9</xref>
###xml 382 383 382 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 468 469 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b004">4</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b010">10</xref>
###xml 669 671 669 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b011">11</xref>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b012">12</xref>
###xml 792 793 792 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b011">11</xref>
###xml 861 863 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b015">15</xref>
###xml 934 936 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b016">16</xref>
###xml 937 939 937 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b023">23</xref>
###xml 1087 1089 1087 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b020">20</xref>
###xml 13 18 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 268 273 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 397 405 <span type="species:ncbi:9606">patients</span>
###xml 444 449 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 543 548 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 587 595 <span type="species:ncbi:9606">patients</span>
###xml 1039 1044 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Treatment of HIV-1-infected individuals with highly active antiretroviral therapy (HAART) can reduce plasma virus levels to below the limit of detection of ultra-sensitive clinical assays [1-3]. However, even in the setting of optimal treatment, replication-competent HIV-1 persists in resting CD4+ T cells [4-8] and possibly in other viral reservoirs (reviewed in [9]). Resting CD4+ T cells from patients on HAART do not spontaneously produce HIV-1 unless activated [4,10]. However, following activation of these cells, replication-competent HIV-1 can be invariably recovered even from patients who have had suppression of viremia on HAART for as long as seven years [11,12]. Taken together, these results demonstrate that a stable state of latent infection can be established in resting CD4+ T cells. The latent reservoir has an extremely slow decay rate [11-15] that will likely preclude virus eradication unless novel approaches [16-23] can purge latently infected cells. Of particular interest are strategies that would induce latent HIV-1 without causing global T-cell activation [20]. The design of such strategies requires an understanding of the molecular mechanisms of latency.
###end p 5
###begin p 6
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 93 94 93 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b004">4</xref>
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b005">5</xref>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b024">24</xref>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b025">25</xref>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b028">28</xref>
###xml 404 405 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b005">5</xref>
###xml 753 754 753 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 82 87 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 228 233 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 286 291 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 678 683 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 797 802 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 915 920 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1105 1110 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Resting CD4+ T cells from infected individuals contain rare cells with integrated HIV-1 DNA [4,5,24], and these cells are presumed to represent the stable latent reservoir, since most studies indicate that unintegrated forms of HIV-1 DNA are labile [25-28]. Among cells with integrated HIV-1 DNA, only a small fraction can be induced to release replication-competent virus following cellular activation [5]. The rest contain defective or permanently silenced viral genomes. Mechanistic studies of latency are thus complicated by the fact that latently infected cells (cells capable of releasing replication-competent virus) represent only a small fraction of the cells carrying HIV-1 DNA, which in turn represent only a small fraction of the resting CD4+ T cell population. Mechanistic studies of HIV-1 latency must be interpreted with these caveats in mind. Because of the difficulties involved in the analysis of HIV-1 latency in vivo, many mechanistic studies have been carried out in cell line systems that may not precisely reflect the physiology of the profoundly quiescent cells that harbor latent HIV-1 in vivo.
###end p 6
###begin p 7
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b029">29</xref>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b032">32</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b033">33</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b034">34</xref>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b035">35</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b039">39</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b034">34</xref>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b040">40</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b032">32</xref>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b041">41</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b042">42</xref>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b043">43</xref>
###xml 623 625 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b047">47</xref>
###xml 719 720 719 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b021">21</xref>
###xml 733 735 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b044">44</xref>
###xml 736 738 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b048">48</xref>
###xml 739 741 739 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b049">49</xref>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b050">50</xref>
###xml 820 822 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b051">51</xref>
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 309 314 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 466 471 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 759 764 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Most of the proposed mechanisms for HIV-1 latency operate at the level of transcription. These include proviral integration into sites that are repressive for transcription [29-32], DNA and histone modifications that inhibit transcription [33,34], the absence of host transcriptional activators necessary for HIV-1 gene expression [35-39], the presence of transcriptional repressors [34,40], transcriptional interference [32,41,42], and the premature termination of HIV-1 transcripts due to the absence of the viral protein Tat and Tat-associated host factors that are critical for efficient transcriptional elongation [43-47]. There are clearly major defects in transcriptional initiation and elongation in resting CD4+ T cells [21,44,48,49], and processive HIV-1 transcripts are difficult to detect in these cells [50,51].
###end p 7
###begin p 8
###xml 290 291 290 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b010">10</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b049">49</xref>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b052">52</xref>
###xml 523 525 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b053">53</xref>
###xml 732 734 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b021">21</xref>
###xml 735 737 735 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b047">47</xref>
###xml 738 740 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b052">52</xref>
###xml 741 743 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b053">53</xref>
###xml 875 877 875 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b043">43</xref>
###xml 878 880 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b046">46</xref>
###xml 881 883 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b054">54</xref>
###xml 884 886 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b055">55</xref>
###xml 974 976 974 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b056">56</xref>
###xml 977 979 977 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b059">59</xref>
###xml 1147 1149 1147 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b021">21</xref>
###xml 1319 1321 1319 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b047">47</xref>
###xml 1396 1397 1396 1397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1407 1409 1407 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b049">49</xref>
###xml 1739 1740 1739 1740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 240 245 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 468 473 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 610 615 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 841 846 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 945 950 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 996 1004 <span type="species:ncbi:9606">patients</span>
###xml 1089 1094 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1296 1301 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1349 1354 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1603 1608 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In addition to these mechanisms affecting transcription, post-transcriptional mechanisms may also contribute to latency. With extremely sensitive methods, some processive transcripts, including both unspliced (US) and multiply spliced (MS) HIV-1 mRNAs, have been demonstrated in resting CD4+ T cells from infected individuals [10,49]. Despite the presence of these transcripts, no virus is produced. This could reflect deficient nuclear export of incompletely spliced HIV-1 RNAs in the absence of the viral protein Rev [52,53]. Interestingly, Rev and the transcriptional activator Tat, are both products of MS HIV-1 RNAs, which have no known export defect. An absence of each of these viral proteins has been implicated in latency [21,47,52,53]. Tat acts at the level of transcription elongation to promote high level transcription from the HIV-1 long terminal repeat (LTR) [43,46,54,55], while Rev promotes export of incompletely spliced viral HIV-1 RNAs to the cytoplasm [56-59]. In cells from patients on HAART, exogenous Tat has been shown to promote positive feedback upregulation of HIV-1 gene expression in cells from infected individuals [21], and a recent study in infected cell lines has shown that stochastic fluctuations in Tat activity can lead to large differences in the levels of HIV-1 gene expression [47]. Given the presence of MS HIV-1 mRNAs encoding Tat and Rev in resting CD4+ T cells [49], it has been unclear why positive feedback does not increase virus gene expression to levels sufficient for virus production. We describe here a post-transcriptional block in the export of MS HIV-1 RNA that may prevent this positive feedback loop. In addition, we identify a host protein which, when overexpressed in resting CD4+ T cells, can reverse latency without inducing cellular activation.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
###xml 51 52 51 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 27 32 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Nuclear Localization of MS HIV-1 RNA in Resting CD4+ T Cells
###end title 10
###begin p 11
###xml 44 45 44 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 64 65 64 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 75 76 75 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b005">5</xref>
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b060">60</xref>
###xml 225 226 225 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 511 512 511 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b005">5</xref>
###xml 424 429 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 593 598 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In vivo, latent viral genomes are found in G0 resting memory CD4+ T cells [5,60]. Because latency may involve aspects of the unique physiology of these profoundly quiescent cells, it is best analyzed using primary resting CD4+ T cells from infected individuals rather than transformed cell lines. However, the analysis of latency in primary cells is complicated by the fact that only a small fraction of the cells harboring HIV-1 DNA in vivo can be induced to produce infectious virus upon cellular activation [5]. The remaining cells may carry defective viruses. In the molecular analysis of HIV-1 DNA or RNA species in primary cell populations, it is not generally possible to distinguish replication-competent from defective forms. Replication-competence can only be established in separate virus outgrowth experiments. By combining data from these two approaches, inferences can be made about the biology of the small subpopulation of cells that harbor replication-competent virus.
###end p 11
###begin p 12
###xml 126 127 126 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b049">49</xref>
###xml 499 500 499 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 586 587 586 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b052">52</xref>
###xml 774 776 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b053">53</xref>
###xml 824 832 824 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g001">Figure 1</xref>
###xml 960 968 960 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g001">Figure 1</xref>
###xml 1109 1110 1109 1110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 61 66 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 141 149 <span type="species:ncbi:9606">patients</span>
###xml 196 201 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 305 310 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 475 480 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 674 679 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 752 757 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 853 858 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1008 1016 <span type="species:ncbi:9606">patients</span>
###xml 1033 1038 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We first analyzed the distribution of the bulk population of HIV-1 RNA molecules in highly purified populations of resting CD4+ T cells from patients on suppressive HAART regimens. Both MS and US HIV-1 mRNAs can be detected in these cells with sensitive methods [49]. To understand why the presence of MS HIV-1 mRNA does not lead to Tat-mediated positive feedback amplification of virus gene expression and virus production, we first examined the subcellular localization of HIV-1 RNA in resting CD4+ T cells. Nuclear, cytoplasmic, and total RNA fractions were isolated from resting CD4+ T cells, and an ultra-sensitive hemi-nested RT-PCR was performed on each fraction. US HIV-1 mRNAs, which have an export defect in the absence of high levels of the HIV-1 Rev protein [52,53], were retained in the nucleus of these cells (Figure 1A). Surprisingly, MS HIV-1 mRNAs, not previously known to have an export defect, were also exclusively nuclear in localization (Figure 1A). The same result was observed in ten patients; both US and MS HIV-1 RNAs were detected only in the nuclear fraction of primary resting CD4+ T cells.
###end p 12
###begin p 13
###xml 238 246 238 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g001">Figure 1</xref>
###xml 398 399 398 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 522 527 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 786 791 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Unspliced and spliced glyceraldehhyde-3-phosphate dehydrogenase (GAPDH) mRNAs were also amplified from these fractions in order to determine the quality of the nuclear-cytoplasmic separation, as well as the integrity of the isolated RNA (Figure 1A). As expected, unspliced GAPDH RNA was localized to the nucleus while the majority of spliced GAPDH mRNA was localized to the cytoplasm of resting CD4+ T cells. This confirms the efficacy of the cell fractionation, and further demonstrates that the aberrant localization of HIV-1 RNA is not due to a global defect in RNA export in these cells. Whether the RNA localization patterns observed in bulk populations of resting cells from infected donors are characteristic of the tiny fraction of cells harboring latent, replication-competent HIV-1 genomes cannot be determined from this analysis.
###end p 13
###begin p 14
###xml 121 122 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 361 369 361 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g001">Figure 1</xref>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b049">49</xref>
###xml 45 50 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 226 231 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 335 340 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 391 396 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To determine whether nuclear localization of HIV-1 RNA is altered in response to T-cell stimulation, purified resting CD4+ T cells were activated with anti-CD3/anti-CD28 for various times and then fractionated. Both MS and US HIV-1 RNAs were localized exclusively to the nucleus until 48 to 72 h following stimulation when cytoplasmic HIV-1 RNAs were detected (Figure 1B). The appearance of HIV-1 RNA in the cytoplasm preceded the release of virus particles into the supernatant by 24-48 h [49].
###end p 14
###begin title 15
###xml 76 77 76 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Identification of MS HIV-1 RNA-Binding Proteins in Resting and Activated CD4+ T Cells
###end title 15
###begin p 16
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 206 207 206 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 302 311 302 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020068-sg001">Figure S1</xref>
###xml 400 409 400 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020068-sg001">Figure S1</xref>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b061">61</xref>
###xml 816 818 816 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b062">62</xref>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b064">64</xref>
###xml 883 885 883 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b065">65</xref>
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 291 296 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 325 330 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 535 540 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 872 877 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 907 912 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The aberrant nuclear localization of MS HIV-1 mRNAs in resting CD4+ T cells could be due to the presence of a negative regulator or the absence of a positive export factor. Primary resting and activated CD4+ T cells were therefore screened for factors that bind specifically to a minimal MS HIV-1 RNA (Figure S1A). Candidate HIV-1 RNA-binding proteins were then identified by PAGE-mass spectrometry (Figure S1B). This screen identified a number of known RNA-binding proteins, including several which have been previously shown to bind HIV-1 RNA. One of these was polypyrimidine tract binding protein (PTB). PTB plays a role in post-transcriptional regulation of gene expression (reviewed in [61]). For example, PTB is involved in post-transcriptional regulation of gene expression in response to T-cell stimulation [62-64]. PTB has been previously shown to associate with HIV-1 RNA [65]. The role of PTB in HIV-1 gene expression has not yet been defined.
###end p 16
###begin p 17
###xml 188 197 188 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020068-sg001">Figure S1</xref>
###xml 275 283 275 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g002">Figure 2</xref>
###xml 607 615 607 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g002">Figure 2</xref>
###xml 45 50 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 129 134 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 226 231 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 383 388 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 495 500 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 569 574 <span type="species:ncbi:4932">yeast</span>
To examine the specificity of PTB binding to HIV-1 RNA, recombinant PTB was incubated with in vitro-transcribed, biotinylated MS HIV-1 RNA bound to streptavidin-conjugated magnetic beads (Figure S1A). Recombinant PTB bound MS HIV-1 RNA and was released upon RNase digestion (Figure 2A). The binding was blocked by pre-incubation of PTB with increasing amounts of non-biotinylated MS HIV-1 RNA. Binding of PTB decreased progressively with increasing ratios of non-biotinylated to biotinylated MS HIV-1 RNA. PTB binding was not decreased by a 5-fold mass excess of total yeast RNA, a non-specific competitor (Figure 2A).
###end p 17
###begin p 18
###xml 75 76 75 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 218 219 218 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 282 283 282 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 407 415 407 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g002">Figure 2</xref>
###xml 760 768 760 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g002">Figure 2</xref>
To determine whether differences in PTB levels in resting and activated CD4+ T cells might be involved in the observed export defect, we first measured steady-state levels of PTB protein in purified primary resting CD4+ T cells and phytohemagglutinin (PHA)-stimulated, activated CD4+ T cells. Quantitative Western analyses indicated that PTB expression increases by at least 4.5-fold upon cell stimulation (Figure 2B). PTB has four known isoforms generated by alternative splicing. Three variants produce bands of 57-59 kDa, while the fourth variant of PTB has an apparent molecular weight of 25 kDa. Only the larger isoforms were upregulated following cellular stimulation, while total levels of the 25-kDa isoform (PTBT) decreased upon cellular stimulation (Figure 2B).
###end p 18
###begin title 19
###xml 73 74 73 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
PTB Overexpression Is Sufficient to Cause Virus Production by Resting CD4+ T Cells from Infected Individuals
###end title 19
###begin p 20
###xml 279 287 279 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g003">Figure 3</xref>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b066">66</xref>
###xml 983 985 983 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b064">64</xref>
###xml 32 37 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 170 175 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The direct binding of PTB to MS HIV-1 RNA, and the differential regulation of PTB isoforms with T-cell stimulation, suggested that PTB might act as a positive factor for HIV-1 gene expression. To test this hypothesis, we generated expression constructs for various forms of PTB (Figure 3A). These included full-length PTB and a mutant form of full-length PTB with a serine to alanine mutation in the nuclear export signal (PTB ser-ala). The N-terminal 55 residues of PTB contain a nuclear localization signal (NLS). PTB ser-ala has a single serine to alanine substitution at position 16 in the nuclear export signal that is also located in this region. This mutation dramatically reduces nucleo-cytoplasmic shuttling of PTB but does not alter nuclear import [66]. We also generated an expression vector for PTBT, the 25-kDA isoform, which lacks an NLS but contains two intact RNA recognition motifs that allow it to interact with cognate RNAs as efficiently as full-length PTB does [64].
###end p 20
###begin p 21
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 542 550 542 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g003">Figure 3</xref>
###xml 972 980 972 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g003">Figure 3</xref>
###xml 1245 1246 1245 1246 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1479 1480 1479 1480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1578 1580 1578 1580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b065">65</xref>
###xml 1581 1583 1581 1583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b067">67</xref>
###xml 1584 1586 1584 1586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b068">68</xref>
###xml 1631 1639 1631 1639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g003">Figure 3</xref>
###xml 26 34 <span type="species:ncbi:9606">patients</span>
###xml 424 429 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 531 536 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1003 1008 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1078 1086 <span type="species:ncbi:9606">patients</span>
###xml 1384 1389 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1567 1572 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Resting CD4+ T cells from patients on HAART were transfected with empty vector, PTB, PTB ser-ala, or PTBT using an Amaxa Nucleofector. At 72 h post-transfection, an ultra-sensitive RT-PCR assay was employed to detect the low levels of virions released into the supernatants of these cultures. In cells transfected with empty vector or PTBT, the amount of virus released was often below the limit of detection (<50 copies of HIV-1 RNA/ml), although occasionally a mock-treated sample would yield a very low-level positive value for HIV-1 RNA (Figure 3B). Because an undetectable viral RNA measurement could represent low levels of virus production and not an actual zero, we considered an undetectable viral load as equivalent to 50 copies/ml when calculating release. The low positive values may represent non-specific stimulation due to in vitro culture. Cells transfected with PTB or PTB ser-ala showed a dramatic (100- to 10,000-fold) upregulation of virus production (Figure 3B). The stimulation of HIV-1 production by PTB transfection was consistently observed in all five patients tested. Although these results do not establish that the virions released are infectious, they do show that PTB overexpression can induce infected resting CD4+ T cells to produce and release virus particles. To determine if the observed upregulation of virus production was specific to PTB, other HIV-1 RNA-binding proteins identified in the proteomic screen were overexpressed in resting CD4+ T cells. Cells transfected with hnRNPA1 or La, other host proteins capable of binding HIV-1 RNA [65,67,68], did not upregulate viral gene expression (Figure 3C).
###end p 21
###begin title 22
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
PTB Expression Specifically Upregulates HIV-1 Gene Expression without Inducing Cellular Activation
###end title 22
###begin p 23
###xml 292 293 292 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 445 453 445 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g004">Figure 4</xref>
###xml 720 728 720 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g004">Figure 4</xref>
###xml 900 908 900 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g004">Figure 4</xref>
###xml 961 962 961 962 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 964 966 964 966 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1a</sub>
###xml 1136 1144 1136 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g004">Figure 4</xref>
###xml 1442 1443 1442 1443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1520 1521 1520 1521 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 1523 1525 1523 1525 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1a</sub>
###xml 1531 1533 1529 1531 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1b</sub>
###xml 1616 1618 1614 1616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b069">69</xref>
###xml 1619 1621 1617 1619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b070">70</xref>
###xml 1597 1602 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To determine if PTB overexpression was inducing virus production non-specifically through general effects on the activation status of the transfected cells, we carefully evaluated transfected cells for expression of well-established markers of cellular activation. PTB-transfected resting CD4+ T cells did not express the activation marker CD25, and only a small fraction (3%) of the cells expressed levels of HLA-DR that were above background (Figure 4A). Following PTB transfection, there was no detectable upregulation of CD69, an early activation marker, at 8 h post-transfection (not shown). In addition, PTB-transfected cells maintained a small, resting cell morphology as shown by the forward scatter profiles in Figure 4A and by the photomicroscopy (see below). As a positive control, we showed that expression of CD25 and HLA-DR were markedly increased by PHA stimulation, as was cell size (Figure 4A). Additionally, transfected cells remained in the G0/G1a phase of the cell cycle. Transfected cells were stained with 7-amino-actinomycin-D/pyronin Y (7AAD/PY) to evaluate DNA/RNA content and cell-cycle status. As is shown in Figure 4B, PTB transfection caused no change in DNA levels and only a slight increase in RNA levels. In contrast, PHA activation caused a dramatic increase in cellular RNA levels followed by entry of cells into the cell cycle. Taken together, these results suggest that overexpression of PTB in resting CD4+ T cells can induce virus production without the wholesale induction of the G0/G1a --> G1b transition that is associated with increased permissiveness to HIV-1 replication [69,70].
###end p 23
###begin title 24
###xml 134 135 134 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
High Level Expression of Tat or PTB Results in Efficient Virus Production Comparable to Virus Production by PHA-Stimulated Resting CD4+ T Cells
###end title 24
###begin p 25
###xml 184 185 184 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 382 383 382 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 570 578 570 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g005">Figure 5</xref>
###xml 813 815 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b021">21</xref>
###xml 816 818 816 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b044">44</xref>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b048">48</xref>
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b049">49</xref>
###xml 872 874 872 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b021">21</xref>
###xml 1011 1013 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b049">49</xref>
###xml 1117 1118 1117 1118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 71 76 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 154 159 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 397 405 <span type="species:ncbi:9606">patients</span>
###xml 434 437 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1305 1310 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The results presented above suggest that the export block affecting MS HIV-1 RNAs encoding the Tat and Rev may contribute to the non-productive nature of HIV-1 infection of resting CD4+ T cells by blocking a positive feedback loop that would result if these RNAs could be translated in the cytosol. To further test this hypothesis, we bypassed this block by transfecting resting CD4+ T cells from patients on HAART with a simple, non-HIV expression vector carrying a Tat cDNA. Tat expressed in this context caused dramatic (1,000-fold) upregulation of virus production (Figure 5) that was even greater than that seen in PTB-transfected cells or in cells stimulated with the mitogen PHA. This result is consistent with previous observations that infected resting cells have a defect in transcriptional elongation [21,44,48,49], and that this defect can be overcome by Tat [21]. These findings can now be reconciled with the observation that resting cells express MS mRNA for Tat and Rev without producing virus [49]. Although MS RNAs encoding these positive regulatory factors are produced at low levels in resting CD4+ T cells, they are retained in the nucleus, and thus no positive feedback is possible. This effect is reversed by increased levels of PTB or a dramatic increase in transcription from the HIV-1 LTR.
###end p 25
###begin title 26
###xml 41 43 41 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+&#8202;</sup>
Partial Knockdown of PTB in Activated CD4+ T Cells Is Not Sufficient to Prevent Virus Production
###end title 26
###begin p 27
###xml 50 51 50 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 133 134 133 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 144 152 144 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g005">Figure 5</xref>
###xml 205 206 205 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 373 374 373 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 418 427 418 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020068-sg002">Figure S2</xref>
###xml 561 562 561 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 263 268 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 400 405 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 480 485 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Because overexpression of Tat alone in resting CD4+ T cells is sufficient to upregulate viral gene expression in infected resting CD4+ T cells (Figure 5), we suspected that the export defect in resting CD4+ T cells may be saturated and overcome at high levels of HIV-1 gene expression. Thus, partial short interfering RNA (siRNA) knockdown of PTB in maximally activated CD4+ T cells did not decrease HIV-1 production (Figure S2). PTB may be overcoming a negative factor affecting HIV-1 RNA export that is readily saturable or that is present only in resting CD4+ T cells.
###end p 27
###begin title 28
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Nuclear Expression of PTB Is Required for Efficient HIV-1 Gene Expression
###end title 28
###begin p 29
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 77 85 77 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g001">Figure 1</xref>
###xml 279 280 279 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 433 441 433 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g006">Figure 6</xref>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b064">64</xref>
###xml 706 714 706 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g006">Figure 6</xref>
###xml 811 819 811 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g006">Figure 6</xref>
###xml 1050 1058 1050 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g003">Figure 3</xref>
###xml 1205 1206 1205 1206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 11 16 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 158 163 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Because MS HIV-1 mRNAs have a nuclear export defect in resting CD4+ T cells (Figure 1), we hypothesized that only nuclear forms of PTB could interact with MS HIV-1 mRNA and facilitate export. Therefore, the nuclear localization of PTB isoforms was examined in primary resting CD4+ T cells by immunofluorescence using an antibody that recognizes all isoforms. In untransfrected cells, endogenous PTB staining was largely cytoplasmic (Figure 6, top panels). This result likely reflects the prominence in resting cells of the PTBT isoform that lacks an NLS and that shows cytoplasmic localization in other cells [64]. Similarly, in PTBT-transfected cells, the majority of PTBT was localized to the cytoplasm (Figure 6, bottom panels). In contrast, cells transfected with PTB exhibited strong nuclear localization (Figure 6, center panels). PTB ser-ala, which carries a disrupted nuclear export signal, also showed strong nuclear localization. Interestingly, cells transfected with PTB ser-ala consistently showed the highest levels of virus production (Figure 3). Taken together, these results suggest that nuclear localization of PTB is important for upregulation of virus production by infected resting CD4+ T cells.
###end p 29
###begin title 30
###xml 75 80 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
PTB Overexpression Does Not Increase Total Intracellular Concentrations of HIV-1 RNA
###end title 30
###begin p 31
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b061">61</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b062">62</xref>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b064">64</xref>
###xml 279 280 279 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 457 465 457 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g007">Figure 7</xref>
###xml 540 542 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b064">64</xref>
###xml 701 709 701 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g007">Figure 7</xref>
###xml 232 237 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 294 302 <span type="species:ncbi:9606">patients</span>
###xml 401 406 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 619 624 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 659 664 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 896 901 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 979 984 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We next asked how nuclear forms of PTB stimulate virus production. In other systems, PTB acts post-transcriptionally through effects on RNA processing and stability [61,62,64]. We measured total steady-state levels of intracellular HIV-1 RNA following transfection of resting CD4+ T cells from patients on HAART with PTB or empty vector. PTB transfection had no observed effect on total intracellular HIV-1 RNA levels compared to mock-transfected controls (Figure 7A). PTB has also been shown previously to stabilize certain cellular RNAs [64]. To examine the possibility that PTB alters the half-life of intracellular HIV-1 RNAs, we measured the turnover of HIV-1 RNAs in cells transfected with PTB (Figure 7B). At 24 h post-transfection, alpha-amanitin was added to cells to block de novo RNA synthesis. Total RNA was isolated at given times, and real-time RT-PCR was performed to detect total HIV-1 RNAs. Transfection with PTB did not substantially alter the turnover rate of HIV-1 RNAs compared with mock-transfected controls.
###end p 31
###begin title 32
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 54 59 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
PTB Expression Alters the Subcellular Distribution of HIV-1 RNAs in Resting CD4+ T Cells In Vivo
###end title 32
###begin p 33
###xml 826 834 826 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g008">Figure 8</xref>
###xml 955 963 955 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g001">Figure 1</xref>
###xml 253 258 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 423 428 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 632 637 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 711 716 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 762 767 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 867 872 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1216 1221 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The ability of PTB to upregulate virus production without altering levels of virus gene expression or viral mRNA stability is consistent with the hypothesis that PTB acts post-transcriptionally in a direct or indirect manner to promote the export of MS HIV-1 mRNAs. This in turn could permit synthesis of Tat and Rev proteins, Tat-mediated upregulation of transcription, and Rev-mediated export of the incompletely spliced HIV-1 mRNAs that encode the structural proteins needed for virion production. To confirm this notion, PTB- and mock-transfected cells were fractionated and assessed for nuclear and cytoplasmic localization of HIV-1 RNAs. Mock-transfected controls showed exclusive nuclear localization of HIV-1 RNAs, while cells expressing PTB accumulated HIV-1 RNAs in the cytoplasm within 48 h following transfection (Figure 8). Cytoplasmic relocalization of HIV-1 RNA occurred more quickly in transfected cells than in cells stimulated with PHA (Figure 1B), reflecting the rapid and robust expression of PTB upon transfection, compared with slower upregulation following mitogen stimulation. Taken together, these results indicate that PTB acts post-transcriptionally in the nucleus to facilitate export of HIV-1 transcripts to the cytoplasm prior to virus production.
###end p 33
###begin title 34
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
PTB Expression Is Sufficient to Reverse HIV-1 Latency and Induce Production of Replication-Competent Virus
###end title 34
###begin p 35
###xml 89 90 89 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 338 339 338 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 796 797 796 797 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1165 1173 1165 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g009">Figure 9</xref>
###xml 1394 1395 1394 1395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1522 1523 1522 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b006">6</xref>
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 104 112 <span type="species:ncbi:9606">patients</span>
###xml 380 385 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 539 544 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 664 669 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 933 938 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1147 1155 <span type="species:ncbi:9606">patients</span>
###xml 1515 1520 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The studies described above show that the low levels of MS HIV-1 RNA found in resting CD4+ T cells from patients on HAART are predominantly localized to the nucleus, and that overexpression of PTB can facilitate export of these forms and induce virion production. While it cannot be definitively shown that the small subset of resting CD4+ T cells harboring replication-competent HIV-1 have similar patterns of RNA localization and respond similarly to PTB, the above results raise the possibility that overexpression of PTB might reverse HIV-1 latency. Therefore, we analyzed the ability of PTB overexpression to stimulate the production of replication-competent HIV-1. The release of replication-competent virus by PTB-transfected cells was measured directly in co-culture experiments using CD4+ T lymphoblasts from normal donors to amplify virus released from infected cells. Virus outgrowth was measured by supernatant levels of HIV-1 p24 antigen. For cells transfected with PTB, and cultured without the addition of blasts, and for mock-transfected cells co-cultured with lymphoblasts, p24 levels remained below the limit of detection in all patients studied (Figure 9). In contrast, when PTB-transfected cells were co-cultured with lymphoblasts, some wells showed readily detectable levels of supernatant p24. Results with PTB-transfected cells were similar to those seen when resting CD4+ T cells were stimulated with the mitogen PHA and then co-cultured with blasts, the standard method for inducing latent HIV-1 [6]. Thus, PTB expression allows the release of replication-competent virus from latently infected cells.
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 84 85 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 198 199 198 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b010">10</xref>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b071">71</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b073">73</xref>
###xml 308 309 308 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 645 646 645 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 775 776 775 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 33 38 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 382 387 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 722 727 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 911 916 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1085 1090 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The molecular mechanism by which HIV-1 establishes a latent infection in resting CD4+ T cells is incompletely understood. There are profound physiologic differences between resting and activated CD4+ T cells [10,71-73], and it is possible that the absence of virus production in latently infected resting CD4+ T cells is a natural consequence of some of these differences. In fact, HIV-1 latency may not have a single mechanism but rather may result from the combined effects of incomplete blocks at multiple steps in the virus life cycle. This study defines a previously unrecognized block in virus gene expression that is unique to resting CD4+ T cells and that may be relevant to latency. Specifically, we show that MS HIV-1 RNAs are retained in the nucleus of resting CD4+ T cells. This block is particularly important because it is positioned so as to interrupt a critical positive feedback loop driven by HIV-1 Tat. We also show that overexpression of nuclear forms of the RNA-binding protein PTB can overcome this block by directly or indirectly promoting the nuclear export of HIV-1 RNAs in a manner that does not induce T-cell activation.
###end p 37
###begin p 38
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b021">21</xref>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b029">29</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b041">41</xref>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b043">43</xref>
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b049">49</xref>
###xml 152 153 152 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b049">49</xref>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b021">21</xref>
###xml 427 428 427 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 521 522 521 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 762 764 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b024">24</xref>
###xml 765 767 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b032">32</xref>
###xml 768 770 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b074">74</xref>
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b075">75</xref>
###xml 962 963 962 963 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 17 22 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 235 240 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 357 360 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 536 544 <span type="species:ncbi:9606">patients</span>
###xml 743 748 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 908 913 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
It is clear that HIV-1 latency is due at least in part to mechanisms that affect transcriptional initiation and elongation [21,29-41,43-49]. Resting CD4+ T cells from infected individuals on HAART have much lower levels of full-length HIV-1 RNA than do activated cells [49]. Interestingly, as shown here and elsewhere [21], overexpression of Tat from a non-HIV vector is sufficient to induce virus production from quiescent CD4+ T cells. Since Tat acts downstream of transcriptional initiation, the failure of resting CD4+ T cells from patients on HAART to produce virus may not be the result of a general inaccessibility of integrated proviruses to the transcriptional machinery. This conclusion is consistent with recent studies of sites of HIV-1 integration [24,32,74,75], which are generally located within introns of active cellular genes. Taken together, these results indicate that some initiation of HIV-1 transcription does occur in infected resting CD4+ T cells, and thus additional blocks operating downstream of transcriptional initiation must contribute to the absence of virion production.
###end p 38
###begin p 39
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b043">43</xref>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b047">47</xref>
###xml 366 367 366 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b021">21</xref>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b048">48</xref>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b049">49</xref>
###xml 645 646 645 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 679 681 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b049">49</xref>
###xml 272 277 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 448 453 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 595 600 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 660 668 <span type="species:ncbi:9606">patients</span>
###xml 838 843 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
One of the most important factors in the failure of infected resting CD4+ T cells to produce virions is likely to be the premature transcriptional termination resulting from the absence of Tat and associated cellular factors required for processive transcription from the HIV-1 LTR [43-47]. Short prematurely terminated transcripts can be demonstrated in resting CD4+ T cells from infected individuals [21,48,49]. However, although the majority of HIV-1 transcripts made in resting cells terminate prematurely, improved methods have allowed the detection of processive transcripts, including MS HIV-1 RNAs, at extremely low levels in resting CD4+ T cells from patients on HAART [49]. Since these mRNAs should give rise to the positive regulatory factors Tat and Rev, it is important to understand why no positive feedback upregulation of HIV-1 gene expression occurs.
###end p 39
###begin p 40
###xml 105 106 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 288 289 288 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 630 631 630 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 671 679 671 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020068-g001">Figure 1</xref>
###xml 80 85 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 129 137 <span type="species:ncbi:9606">patients</span>
###xml 164 169 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 240 245 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 659 664 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To address this question, we examined the subcellular localization of MS and US HIV-1 RNAs in resting CD4+ T cells isolated from patients on HAART. Both species of HIV-1 RNA were localized to the nucleus of these cells. The finding that MS HIV-1 mRNAs remain in the nucleus of resting CD4+ T cells has not been previously reported. This result is important because it helps to explain why positive feedback does not occur and defines an additional block at the post-transcriptional level, which prevents expression of all viral protein products. This post-transcriptional block does not appear to be a global defect in resting CD4+ T cells and is specific to HIV-1 RNAs (Figure 1A).
###end p 40
###begin p 41
###xml 430 431 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 474 475 474 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 83 88 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 199 204 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 301 306 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 353 358 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 489 497 <span type="species:ncbi:9606">patients</span>
###xml 655 660 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To understand the nature of this block, a proteomic screen for proteins binding MS HIV-1 RNA was performed using a robust approach that successfully identified many proteins previously known to bind HIV-1 RNA or to be general RNA-binding proteins. PTB was studied as a potential positive modulator of HIV-1 gene expression due to its ability to bind MS HIV-1 RNA as well as its differential regulation in resting and activated CD4+ T cells. When overexpressed in resting CD4+ T cells from patients on HAART, PTB was sufficient to allow for high-level virus production without inducing cellular stimulation. This effect was specific to PTB, as other known HIV-1 RNA-binding proteins tested had no effect on virus production. The effect was also specific to nuclear forms of PTB as overexpression of PTBT, a cytoplasmic isoform, had no effect on virus production.
###end p 41
###begin p 42
###xml 98 99 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 263 264 263 264 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 289 290 289 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 459 460 459 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 940 941 940 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1116 1117 1116 1117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 62 67 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 318 323 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 426 431 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 606 609 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 846 851 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The delineation of this export block required the analysis of HIV-1 gene expression in primary CD4+ T cells. Although many elegant studies of latency have been carried out in transformed cell lines, these cells do not fully recapitulate the profoundly quiescent G0 state of the resting CD4+ T cells that harbor latent HIV-1 in vivo. This block was not detected previously because few studies have examined the localization of HIV-1 RNAs in primary resting CD4+ T cells, cells in which the levels of nuclear forms of PTB are low. Interestingly, the block can be overcome by overexpression of Tat from a non-HIV vector. In this situation, Tat-mediated upregulation of transcriptional elongation allows virus production. Thus, it may be that the nuclear export block observed in resting cells is saturable, or that it can be overcome when levels of HIV-1 transcripts increase beyond a threshold value. Partial knockdown of PTB in activated CD4+ T cells did not affect virus production. Thus, the clinical significance of this finding is likely to be in novel approaches for inducing virus gene expression in resting CD4+ T-infected cells (purging the latent reservoir) rather than in inhibiting virus production by fully activated cells.
###end p 42
###begin p 43
###xml 85 86 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 330 331 330 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1320 1321 1320 1321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1683 1684 1683 1684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1883 1884 1883 1884 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 61 66 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 237 242 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 305 310 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 605 610 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 627 632 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 824 829 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 972 977 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1028 1033 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1151 1156 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1202 1207 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1295 1300 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1346 1354 <span type="species:ncbi:9606">patients</span>
###xml 1633 1638 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Delineation of the mechanism for the nuclear retention of MS HIV-1 RNA in resting CD4+ T cells, and of the PTB reversal of this block, remains to be accomplished and may require the development of a more tractable system where levels of HIV-1 RNA can be more easily modulated. The nuclear retention of MS HIV-1 RNAs in resting CD4+ T cells may result from inefficient transcription by RNA pol II complexes that are not properly phosphorylated on the C-terminal domain due to the absence of Tat and associated host factors. This inefficient transcription could result in improper processing of the nascent HIV-1 mRNAs. Although HIV-1 mRNAs in resting cells appear functional by sequence analysis, assembly of downstream cellular RNA export factors may be disrupted, resulting in nuclear retention of these RNAs. PTB binds MS HIV-1 RNA and acts post-transcriptionally to overcome this obstacle and therefore allows for virus production. Whether the PTB-mediated reversal of HIV-1 latency is a direct consequence of PTB binding to HIV-1 RNA remains to be determined. Indeed, it is not possible to assert from the results presented here that PTB reverses HIV-1 latency by allowing the nuclear export of MS HIV-1 RNA. It is clear that PTB overexpression can alter the distribution of the majority of HIV-1 RNAs in resting CD4+ T cell populations from patients on HAART. It is also clear that PTB overexpression can induce latently infected cells in these populations to release replication-competent virus. However, it remains formally possible that these are two separate effects. In other words, PTB may be altering the distribution of HIV-1 RNAs in the majority of infected resting CD4+ T cells but reversing latency through a separate, as yet unidentified mechanism. Despite this caveat, it remains clear that PTB can induce the release of replication-competent virus from resting CD4+ T cells.
###end p 43
###begin p 44
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b016">16</xref>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b021">21</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b023">23</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b020">20</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b021">21</xref>
###xml 151 156 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Efforts to eliminate a latent reservoir have focused on strategies that induce some level of T-cell activation in order to render cells permissive for HIV-1 gene expression [16-21,23]. Because of the potential toxicities associated with non-specific T-cell activation, there has been interest in approaches that would selectively induce viral gene expression [20,21]. Thus, obtaining a greater understanding of the mechanism of this PTB effect may contribute to the development of strategies for targeting this critical viral reservoir without inducing global T-cell activation.
###end p 44
###begin title 45
Materials and Methods
###end title 45
###begin title 46
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients.
###end title 46
###begin p 47
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 54 59 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 129 134 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Resting CD4+ T cells were obtained from asymptomatic, HIV-1-infected adults who had suppression of viremia to below 50 copies of HIV-1 RNA/ml on HAART for at least 6 mo.
###end p 47
###begin title 48
RNA isolation and RT-PCR.
###end title 48
###begin p 49
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 391 392 391 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 497 498 491 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 629 630 623 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 925 927 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b049">49</xref>
Total RNA was isolated from 106 purified resting CD4+ T cells (described below) using the RNeasy Mini Kit (Qiagen, Valencia, California, United States). To obtain nuclear and cytoplasmic extracts, cells were lysed on ice for 5-10 min in lysis buffer containing 10 mM TrisCl [pH 7.5], 140 mM NaCl, 5 mM KCl, 1% NP-40, 1,000 U/ml RNase inhibitor, and 1 mM DTT. Lysates were centrifuged at 270 g for 5 min at 4degrees to pellet nuclei. Cytoplasmic supernatants were removed and centrifuged at 13,000 g for 5 min to clear any contaminating nuclei. Nuclei were incubated in RNeasy lysis buffer for 5 min on ice and centrifuged at 270 g for 5 min. RNA was then isolated from cytoplasmic and nuclear fractions using RNeasy. All RNAs were DNase-treated with DNase I (Amplification Grade, Invitrogen, Carlsbad, California, United States). RT-PCR was performed as described previously using hemi-nested PCR primer sets US, E2, and E5 [49]. All RT-PCR experiments included control reactions set up without the addition of RT, as well as no template controls. All such controls were negative. Real-time RT-PCR was performed using the Platinum Quantitative RT-PCR ThermoScript One-Step System (Invitrogen) according to the manufacturer's protocol. Primers and probe for quantitative RT-PCR were as follows: QPCR LTR3': 5' TAAAAGGGTCTGA-GGGATCTCTAGTT3', QPCR LTR5': 5' GCCTCAATAAAGCTTGCCTTGA3', probe: 5' FAM-AGTCACACAACAGACGGGCACACACTACTT-BlackHole Quencher1-3'. Probes were obtained from Biosource International. The quantitative real time RT-PCR has a limit of detection of 10-100 copies. The semi-quantitative method has a limit of detection of ~10 copies.
###end p 49
###begin title 50
###xml 9 14 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In vitro HIV-1 RNA-binding assays.
###end title 50
###begin p 51
###xml 652 653 642 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 3 8 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 47 54 <span type="species:ncbi:9606">patient</span>
###xml 119 124 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 237 242 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
MS HIV-1 RNA was cloned from RNA isolated from patient PBMCs (peripheral blood mononuclear cells). Reverse transcribed HIV-1 RNA containing exons 1, 5, and 7 was cloned into pSP64 Poly(A) (Promega, Madison, Wisconsin, United States). MS HIV-1 RNA was produced by in vitro transcription using the RiboMAXtrade mark Large Scale RNA Production System (Promega) according to manufacturer's protocol. The resulting RNA was incubated with an equimolar amount of a biotinylated oligo-dT probe coupled to streptavidin magnetic particles (Roche, Basel, Switzerland). The RNA-coated beads were incubated with lyastes (50 mug) of purified resting or activated CD4+ T cells. RNA-binding proteins were identified by PAGE MS/MS using the mass spectrometry facility of Dr. Bill Lane at Harvard Medical School. For recombinant protein binding assays, 50 ng of protein was used.
###end p 51
###begin title 52
Recombinant proteins.
###end title 52
###begin p 53
###xml 177 184 <span type="species:ncbi:4097">Tobacco</span>
###xml 495 498 <span type="species:ncbi:12227?0.9375|species:ncbi:11084?0.0390625">TEV</span>
cDNA encoding full-length PTB isoform 1 (kind gift of S. Bouyain and B. Geisbrecht) was cloned into the pT7 vector, which encodes an N-terminal poly-histidine tag followed by a Tobacco Etch Virus cleavage site. Recombinant protein was expressed in Rosetta pLysS expression hosts (EMD Biosciences), and soluble protein was purified using nickel-loaded Chelating Fast Flow resin (Amersham Biosciences, Little Chalfont, United Kingdom). The partially purified protein was cleaved using recombinant TEV protease (Invitrogen), and fully cleaved protein from a reverse IMAC purification was further purified to near homogeneity using a Superdex S-200 gel filtration column (Amersham Biosciences). Protein concentration was determined using the UV spectroscopy at 278 nm.
###end p 53
###begin title 54
Antibodies, Western blots, and immunofluorescence.
###end title 54
###begin p 55
Anti-PTB was obtained from Zymed (San Francisco, California, United States). For Western blots, a 1:350 dilution of antibody was used, and for immunofluorescence, a 1:250 dilution was used. Both La and hnRNPA1 antibodies were used at a concentration of 0.5 mug/ml for Western blots. 20 mug of total protein were loaded per lane for Western blots. For immunofluorescence, AlexoFluor596 (Molecular Probes, Eugene, Oregon, United States) was used as a secondary reagent according to manufacturer's protocol. OregonGreen 488 phalloidin was used for actin staining according to manufacturer's protocol (Molecular Probes). Nuclear staining was performed with DAPI (Molecular Probes) using ProLong Gold antifade reagent. Images were taken using a Perkin Elmer (Wellesley, Massachusetts, United States) UltraVIEW Spinning Disk Confocal Microscope.
###end p 55
###begin title 56
T-cell purification and transfections.
###end title 56
###begin p 57
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b006">6</xref>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b049">49</xref>
###xml 132 133 132 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 206 207 206 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 275 276 275 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 358 359 358 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 372 373 372 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 413 414 412 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 636 643 <span type="species:ncbi:9606">patient</span>
Resting CD4+ T cells were isolated through a two-step purification procedure as previously described [6,49]. To obtain activated CD4+ T cells, Ficoll-purified PBMCs were stimulated with PHA for 3 d, and CD4+ T cells were positively selected using the Dynal (Oslo, Norway) CD4+ selection kit. Transfections were performed using an Amaxa Nucleofector. 2-4 x 106 purified CD4+ T cells were re-suspended in 100 mul/106 cell in nucleofector solution and transfected using program U-14. The number of cells used depended on the number of cells obtained after purification. Cells were cultured in 1.5 ml medium after transfection. For a given patient, the number of cells used was identical for each condition. For each transfection, 2.5 mug of empty vector or plasmid with PTB, PTBS-A, PTBT, or pcDNA-TAT-86 was transfected with 2.5 mug of plasmid phMGFP (Promega). GFP expression served as a control for transfection efficiency. For RNA-turnover experiments, alpha-amanitin was added to medium at a final concentration of 50 mug/ml 24 h after transfection. Total RNA was isolated at various time points after alpha-amanitin addition. PTB and PTBT were cloned from PBMC cDNA using the following primers: 5'ACGCGTCGACAATGGACGGCATTGTCCCAGATATAGCC3' and 5'ATAGAATGCGGCCGCCTAGATGGTGGACTTGGAGAAGG3'. PCR products were cloned using SalI and NotI restriction sites into the pCI-neo mammalian expression vector (Promega). PTB ser-ala was made by direct mutagenesis of serine16 to alanine in the PTB expression vector. pcDNA-TAT-86 was a gift from Dr. Avi Nath (Johns Hopkins University, Baltimore, Maryland, United States).
###end p 57
###begin title 58
T-cell co-culture.
###end title 58
###begin p 59
###xml 137 138 137 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 200 201 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b006">6</xref>
###xml 215 216 215 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 480 481 480 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 573 574 573 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020068-b006">6</xref>
###xml 244 252 <span type="species:ncbi:9606">patients</span>
To isolate replication competent viruses from latently infected cells after PTB transfection, transfected cells were co-cultured with CD4+ lymphoblasts from uninfected donors as described previously [6]. Resting CD4+ T cells were isolated from patients on HAART and transfected as described above. At 24 h after transfection, lymphoblasts were added to each well at a ratio of 2:1 to amplify virus released from latently infected cells. In control wells, untransfected resting CD4+ T cells were activated with PHA and co-cultured with lymphoblasts as previously described [6]. Supernatants were sampled every day over a 2-wk period, and levels of p24 antigen were measured by ELISA.
###end p 59
###begin title 60
Supporting Information
###end title 60
###begin title 61
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Proteomic Screen for MS HIV-1 RNA-Binding Proteins
###end title 61
###begin p 62
###xml 168 169 168 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 41 46 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 135 140 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 286 291 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) Schematic of in vitro-transcribed MS HIV-1 RNA used in binding assays. This RNA contains exons 1, 5, and 7. (B) Silver stain of MS HIV-1 RNA-binding proteins in CD4+ T cells. Bands that decreased in intensity with increasing molar equivalents of competitor RNA (non-biotinylated MS HIV-1 RNA) were analyzed (arrows).
###end p 62
###begin p 63
(184 KB DOC)
###end p 63
###begin p 64
Click here for additional data file.
###end p 64
###begin title 65
###xml 68 69 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Effect of siRNA Knockdown of PTB on Virus Production by Infected CD4+ T Lymphoblasts
###end title 65
###begin p 66
###xml 229 230 229 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 285 286 285 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 256 261 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 300 308 <span type="species:ncbi:9606">patients</span>
(A) Semi-quantitative RT-PCR of full-length PTB in cells transfected with a non-targeting siRNA or a siRNA directed against PTB. Semi-quantitative RT-PCR for GAPDH served as an input control. (B) Knockdown of PTB in activated CD4+ T cells had no effect on HIV-1 production. Resting CD4+ T cells from patients on HAART were activated with PHA and then transfected 48 h post-stimulation with a non-targeting siRNA or a siRNA directed against PTB. Cells were washed every 24 h and supernatants were analyzed for viral load 72 h post-transfection.
###end p 66
###begin p 67
(36 KB DOC)
###end p 67
###begin p 68
Click here for additional data file.
###end p 68
###begin title 69
Accession Numbers
###end title 69
###begin p 70
The National Center for Biotechnology (NCBI) () accession number for polypyrimidine tract binding protein (PTB) is NM_002819.3.
###end p 70
###begin p 71
###xml 64 72 <span type="species:ncbi:9606">patients</span>
We would like to thank Mike Paradise for his help in recruiting patients and Doug Black for helpful discussions.
###end p 71
###begin title 72
Abbreviations
###end title 72
###begin p 73
glyceraldehhyde-3-phosphate dehydrogenase
###end p 73
###begin p 74
highly active antiretroviral therapy
###end p 74
###begin p 75
long terminal repeat
###end p 75
###begin p 76
multiply spliced
###end p 76
###begin p 77
nuclear localization signal
###end p 77
###begin p 78
phytohemagglutinin
###end p 78
###begin p 79
polypyrimidine tract binding protein
###end p 79
###begin p 80
PTB with a serine to alanine mutation
###end p 80
###begin p 81
a 25-kDa cytoplasmic isoform
###end p 81
###begin p 82
short interfering RNA
###end p 82
###begin p 83
unspliced
###end p 83
###begin title 84
References
###end title 84
###begin article-title 85
###xml 68 96 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy [see comments]
###end article-title 85
###begin article-title 86
###xml 65 72 <span type="species:ncbi:9606">persons</span>
###xml 78 106 <span type="species:ncbi:12721">human immunodeficiency virus</span>
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team
###end article-title 86
###begin article-title 87
###xml 25 30 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Decay characteristics of HIV-1-infected compartments during combination therapy
###end article-title 87
###begin article-title 88
###xml 16 21 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency
###end article-title 88
###begin article-title 89
###xml 64 69 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Quantitation of latent tissue reservoirs and total body load in HIV-1 infection
###end article-title 89
###begin article-title 90
###xml 34 39 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 43 51 <span type="species:ncbi:9606">patients</span>
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
###end article-title 90
###begin article-title 91
###xml 34 37 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
###end article-title 91
###begin article-title 92
###xml 25 30 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
###end article-title 92
###begin article-title 93
###xml 25 30 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The latent reservoir for HIV-1 in resting CD4+ T cells and other viral reservoirs during chronic infection: Insights from treatment and treatment interruption trials
###end article-title 93
###begin article-title 94
###xml 107 110 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Gene expression and viral production in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals
###end article-title 94
###begin article-title 95
###xml 82 87 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 97 105 <span type="species:ncbi:9606">patients</span>
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
###end article-title 95
###begin article-title 96
###xml 78 83 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
###end article-title 96
###begin article-title 97
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 42 50 <span type="species:ncbi:9606">patients</span>
Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy
###end article-title 97
###begin article-title 98
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged antiretroviral therapy
###end article-title 98
###begin article-title 99
###xml 70 73 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: Intrinsic stability predicts life-long persistence
###end article-title 99
###begin article-title 100
###xml 82 87 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 97 105 <span type="species:ncbi:9606">patients</span>
Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active antiretroviral therapy
###end article-title 100
###begin article-title 101
###xml 33 38 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Prostratin: Activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART
###end article-title 101
###begin article-title 102
###xml 44 79 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 103 110 <span type="species:ncbi:9606">persons</span>
Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy
###end article-title 102
###begin article-title 103
###xml 47 75 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Effects of prostratin on T-cell activation and human immunodeficiency virus latency
###end article-title 103
###begin article-title 104
###xml 43 78 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype
###end article-title 104
###begin article-title 105
###xml 35 63 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Transcriptional profiles of latent human immunodeficiency virus in infected individuals: Effects of Tat on the host and reservoir
###end article-title 105
###begin article-title 106
###xml 23 26 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Prostratin antagonizes HIV latency by activating NF-kappaB
###end article-title 106
###begin article-title 107
###xml 20 25 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Depletion of latent HIV-1 infection in vivo: A proof-of-concept study
###end article-title 107
###begin article-title 108
###xml 26 31 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 70 75 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Resting CD4+ T cells from HIV-1-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes
###end article-title 108
###begin article-title 109
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
###end article-title 109
###begin article-title 110
###xml 45 80 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro
###end article-title 110
###begin article-title 111
###xml 58 63 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Biphasic decay of latently infected CD4+ T cells in acute HIV-1 infection
###end article-title 111
###begin article-title 112
###xml 12 47 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells
###end article-title 112
###begin article-title 113
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 latency due to the site of proviral integration
###end article-title 113
###begin article-title 114
###xml 18 23 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The regulation of HIV-1 gene expression: The emerging role of chromatin
###end article-title 114
###begin article-title 115
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV reproducibly establishes a latent infection after acute infection of T cells in vitro
###end article-title 115
###begin article-title 116
###xml 56 84 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription
###end article-title 116
###begin article-title 117
###xml 109 144 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 146 151 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 160 165 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 184 189 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat
###end article-title 117
###begin article-title 118
###xml 23 26 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation
###end article-title 118
###begin article-title 119
###xml 58 86 <span type="species:ncbi:12721">human immunodeficiency virus</span>
An inducible transcription factor activates expression of human immunodeficiency virus in T cells
###end article-title 119
###begin article-title 120
###xml 0 28 <span type="species:ncbi:12721">Human immunodeficiency virus</span>
Human immunodeficiency virus long terminal repeat responds to T-cell activation signals
###end article-title 120
###begin article-title 121
###xml 122 125 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV
###end article-title 121
###begin article-title 122
###xml 38 73 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat
###end article-title 122
###begin article-title 123
###xml 33 38 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes
###end article-title 123
###begin article-title 124
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 42 77 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1
###end article-title 124
###begin article-title 125
###xml 29 34 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The multifactorial nature of HIV-1 latency
###end article-title 125
###begin article-title 126
###xml 26 61 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 63 68 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 108 113 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes
###end article-title 126
###begin article-title 127
###xml 69 74 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Anti-termination of transcription within the long terminal repeat of HIV-1 by Tat gene product
###end article-title 127
###begin article-title 128
###xml 20 48 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts
###end article-title 128
###begin article-title 129
Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: Candidate for a Tat cofactor
###end article-title 129
###begin article-title 130
###xml 102 137 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation
###end article-title 130
###begin article-title 131
###xml 67 72 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity
###end article-title 131
###begin article-title 132
###xml 61 64 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Limitation of Tat-associated transcriptional processivity in HIV-infected PBMC
###end article-title 132
###begin article-title 133
###xml 12 47 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Analysis of human immunodeficiency virus type 1 transcriptional elongation in resting CD4+ T cells in vivo
###end article-title 133
###begin article-title 134
###xml 66 69 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Molecular characterization, reactivation, and depletion of latent HIV
###end article-title 134
###begin article-title 135
###xml 12 17 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Analysis of HIV-1 gene expression in latently infected resting CD4+ T lymphocytes in vivo
###end article-title 135
###begin article-title 136
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: A molecular model for latency
###end article-title 136
###begin article-title 137
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 114 119 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 structural gene expression requires the binding of multiple rev monomers to the viral RRE: Implications for HIV-1 latency
###end article-title 137
###begin article-title 138
###xml 32 37 <span type="species:ncbi:9606">human</span>
The trans-activator gene of the human T cell lymphotropic virus type III is required for replication
###end article-title 138
###begin article-title 139
The trans-activator gene of HTLV-III is essential for virus replication
###end article-title 139
###begin article-title 140
A second post-transcriptional trans-activator gene required for HTLV-III replication
###end article-title 140
###begin article-title 141
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA
###end article-title 141
###begin article-title 142
###xml 15 50 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA
###end article-title 142
###begin article-title 143
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence
###end article-title 143
###begin article-title 144
###xml 90 95 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Characterization of chemokine receptor utilization of viruses in the latent reservoir for HIV-1
###end article-title 144
###begin article-title 145
Regulation of alternative splicing by PTB and associated factors
###end article-title 145
###begin article-title 146
A complex containing polypyrimidine tract-binding protein is involved in regulating the stability of CD40 ligand (CD154) mRNA
###end article-title 146
###begin article-title 147
Nucleolin is a second component of the CD154 mRNA stability complex that regulates mRNA turnover in activated T cells
###end article-title 147
###begin article-title 148
Delineation of a novel pathway that regulates CD154 (CD40 ligand) expression
###end article-title 148
###begin article-title 149
###xml 73 78 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Specific binding of polypyrimidine tract binding protein and hnRNP A1 to HIV-1 CRS elements
###end article-title 149
###begin article-title 150
Protein kinase A phosphorylation modulates transport of the polypyrimidine tract-binding protein
###end article-title 150
###begin article-title 151
###xml 27 32 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1
###end article-title 151
###begin article-title 152
hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer
###end article-title 152
###begin article-title 153
###xml 77 112 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells
###end article-title 153
###begin article-title 154
###xml 66 69 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Identification of T-cell signaling pathways that stimulate latent HIV in primary cells
###end article-title 154
###begin article-title 155
Contingent genetic regulatory events in T lymphocyte activation
###end article-title 155
###begin article-title 156
Activation changes the spectrum but not the diversity of genes expressed by T cells
###end article-title 156
###begin article-title 157
Fuel feeds function: Energy metabolism and the T-cell response
###end article-title 157
###begin article-title 158
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 25 30 <span type="species:ncbi:9606">human</span>
HIV-1 integration in the human genome favors active genes and local hotspots
###end article-title 158
###begin article-title 159
###xml 35 40 <span type="species:ncbi:9606">human</span>
Transcription start regions in the human genome are favored targets for MLV integration
###end article-title 159
###begin title 160
Figures and Tables
###end title 160
###begin title 161
###xml 64 65 64 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 15 20 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 79 87 <span type="species:ncbi:9606">Patients</span>
Both MS and US HIV-1 RNAs Localize to the Nucleus of Resting CD4+ T Cells from Patients on HAART
###end title 161
###begin p 162
###xml 121 122 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 143 144 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 33 38 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 160 167 <span type="species:ncbi:9606">patient</span>
(A) RT-PCR analysis of US and MS HIV-1 RNAs in nuclear (N), cytoplasmic (C), and total (T) RNA fractions isolated from 106 purified resting CD4+ T cells from a patient on HAART. Unspliced GAPDH and spliced GAPDH were used as internal controls for fraction purity and RNA integrity.
###end p 162
###begin p 163
###xml 71 72 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 84 85 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 57 62 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 317 322 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(B) Effect of cellular activation on the localization of HIV-1 RNAs. 106 resting CD4+ T cells were stimulated with anti-CD3 and anti-CD28. Nuclear (N), cytoplasmic (C), and total (T) RNA fractions were isolated at given times post-activation and analyzed as above with primers to detect US (shown) and MS (not shown) HIV-1 RNAs. Similar results were obtained with both US and MS primer sets.
###end p 163
###begin title 164
###xml 29 34 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
PTB Binds Specifically to MS HIV-1 RNA and Is Upregulated upon Cellular Stimulation
###end title 164
###begin p 165
###xml 33 38 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 152 157 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 191 196 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 265 270 <span type="species:ncbi:4932">yeast</span>
###xml 338 343 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) PTB binds specifically to MS HIV-1 RNA. Recombinant PTB was pre-incubated with increasing molar equivalents (0X, 1X, 2X, 5X) of non-biotinylated MS HIV-1 RNA (relative to biotinylated MS HIV-1 RNA) or a 5-fold mass excess of non-specific (NS) competitor, total yeast RNA; and then incubated with biotinylated, in vitro-transcribed MS HIV-1 RNA bound to streptavidin-conjugated magnetic particles. PTB protein eluted by RNase digestion was analyzed by Western blot.
###end p 165
###begin p 166
###xml 129 130 129 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
(B) PTB expression increases in response to T-cell stimulation. Expression of PTB was measured by Western blotting in resting CD4+ T cells cultured for 72 h without activating stimuli (-) or with (+) anti-CD3/anti-CD28. Vinculin served as a loading control.
###end p 166
###begin title 167
###xml 80 81 80 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 44 49 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
PTB Overexpression Is Sufficient to Reverse HIV-1 Latency in Primary Resting CD4+ T Cells
###end title 167
###begin p 168
(A) Diagram of expression constructs. The PTB construct contains full-length PTB including a NLS and four RNA recognition motifs (RRM). PTB ser-ala has a single serine to alanine substitution at position 16 in the NES located within the NLS region. PTBT is the 25 kDA isoform which lacks an NLS but contains two intact RRMs.
###end p 168
###begin p 169
###xml 103 104 103 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 134 135 134 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 149 157 <span type="species:ncbi:9606">patients</span>
(B) Overexpression of PTB and PTB ser-ala is sufficient to upregulate virus production from resting CD4+ T cells. Purified resting CD4+ T cells from patients on HAART were transfected with the indicated constructs. Culture supernatants were isolated 72 h post-transfection and analyzed for viral RNA. Dotted line represents the limit of detection of the assay.
###end p 169
###begin p 170
###xml 95 96 95 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 138 139 138 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 38 43 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 108 116 <span type="species:ncbi:9606">patients</span>
###xml 265 270 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(C) Other cellular proteins that bind HIV-1 RNA cannot induce virus production from resting CD4+ T cells of patients on HAART. Resting CD4+ T cells were transfected as described above with empty vector or hnRNP A1 (left panel) and empty vector or La (right panel). HIV-1 RNA levels in the supernatants 72 h after transfection are shown.
###end p 170
###begin title 171
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
PTB Expression Specifically Upregulates HIV-1 Gene Expression without Inducing Cellular Activation
###end title 171
###begin p 172
###xml 75 76 75 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
(A) Expression of activation markers on PTB-transfected primary resting CD4+ T cells. PTB-transfected cells were analyzed 24, 48 (shown), and 72 h post-transfection for surface expression of CD25 and HLA-DR. Cells were stained with phycoerythrin-conjugated isotype control antibody, anti-CD25, or anti-HLA-DR. Cell size is indicated by the forward scatter (FSC) values on the Y-axis.
###end p 172
###begin p 173
###xml 52 54 52 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1b</sub>
(B) PTB-transfected cells do not transition to the G1b stage of the cell cycle. Mock-transfected and PTB-transfected cells and PHA-stimulated cells were stained with PY and 7AAD to measure RNA and DNA levels, respectively. Dye binding was assessed by flow cytometry.
###end p 173
###begin title 174
Induction of Virus Production by PTB or Tat
###end title 174
###begin p 175
###xml 50 51 50 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 178 179 178 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 65 73 <span type="species:ncbi:9606">patients</span>
###xml 202 210 <span type="species:ncbi:9606">patients</span>
###xml 383 388 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 484 489 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
High-level expression of PTB or Tat in resting CD4+ T cells from patients on HAART induces virus production that is comparable to that seen following PHA stimulation. Resting CD4+ T cells purified from patients on HAART were transfected as described above with expression vectors for PTB or Tat, or as a positive control, were stimulated with PHA. For all transfections, supernatant HIV-1 levels were measured at 72 h post-stimulation. For PHA-stimulated cells, supernatant levels of HIV-1 RNA were measured every day for a 6-d period. Levels shown reflect peak virus release over the 6-d period.
###end p 175
###begin title 176
PTB Localization in Transfected Primary Cells
###end title 176
###begin p 177
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 285 286 285 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Resting CD4+ T cells were mock-transfected or were transfected with the expression construct indicated on far left and stained as indicated on the top. Cells were stained with DAPI (blue) and with antibodies to actin (green) and PTB (red). Immunofluorescence of transfected resting CD4+ T cells demonstrated strong nuclear localization of both PTB and PTB ser-ala (speckled pink/blue pattern in nucleus). Transfected cells are indicated with arrows.
###end p 177
###begin title 178
###xml 81 86 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Overexpression of PTB Does Not Increase in Total Intracellular Concentrations of HIV-1 RNA
###end title 178
###begin p 179
###xml 92 93 92 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 109 110 109 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 155 156 155 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 27 32 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 326 331 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) Steady-state levels of HIV-1 RNA are not increased by overexpression of PTB. Resting CD4+ T cells (4 x 106) were transfected as described above. 1 x 106 cells were isolated at various times post-transfection. Total cellular RNA was isolated, and quantitative real-time RT-PCR was performed using primers that detect total HIV-1 transcripts.
###end p 179
###begin p 180
###xml 63 64 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 80 81 80 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 31 36 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 302 307 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(B) PTB has no major effect on HIV-1 RNA stability. Resting CD4+ T cells (4 x 106) were transfected as described above. At 24 h post-transfection, alpha-amanitin was added to cells to block de novo RNA synthesis. Total RNA was isolated at given times and real-time RT-PCR was performed to detect total HIV-1 RNAs.
###end p 180
###begin title 181
###xml 87 88 87 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 54 59 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 102 110 <span type="species:ncbi:9606">patients</span>
PTB Expression Alters the Subcellular Distribution of HIV-1 RNAs in Primary Resting CD4+ T Cells from patients on HAART
###end title 181
###begin p 182
###xml 139 140 139 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 234 239 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Nuclear (N), cytoplasmic (C), and total (T) RNA fractions were isolated from mock-transfected (left) or PTB-transfected (right) resting CD4+ T cells 24 and 48 h post-transfection. RNA fractions were analyzed with primers to detect US HIV-1 RNA.
###end p 182
###begin title 183
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
PTB Expression Is Sufficient to Reverse HIV-1 Latency and to Induce the Production of Replication-Competent Virus
###end title 183
###begin p 184
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 212 213 212 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 26 34 <span type="species:ncbi:9606">patients</span>
###xml 364 372 <span type="species:ncbi:9606">patients</span>
Resting CD4+ T cells from patients on HAART were transfected with empty vector, or a PTB expression vector, or were stimulated with PHA. Where indicated, cells were then co-cultured with uninfected, activated CD4+ T cells. Supernatant p24 levels were measured daily over a 2-wk period. Peak p24 levels are shown for each condition. Results from two representative patients are shown.
###end p 184
###begin p 185
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. KGL conceived and designed the experiments. KGL, KXR, and JRB performed the experiments. KGL and RFS analyzed the data. KXR, JRB, and YZ contributed reagents/materials/analysis tools. KGL and RFS wrote the paper.
###end p 185
###begin p 186
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 186
###begin p 187
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This work was supported by National Institutes of Health grant AI43222, by the Doris Duke Charitable Foundation, and by the Howard Hughes Medical Institute.
###end p 187

